Beam Therapeutics BEAM Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Beam Therapeutics (BEAM) reported comprehensive income (loss), net of tax, attributable to parent of -$96.5M in Q1 2026.
- How has Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent increased by 11.3% year-over-year, from -$108.85M to -$96.5M.
- What is the long-term trend for Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent?
- Over 2 years (2021 to 2024), Beam Therapeutics's comprehensive income (loss), net of tax, attributable to parent has grown at a 0.8% compound annual growth rate (CAGR), from -$370.68M to -$376.67M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, including net income and other comprehensive income items such as foreign currency translation adjustments or unrealized gains on securities. It provides a more holistic view of the company's financial performance beyond traditional net income by capturing broader economic impacts. Investors use this to evaluate the total change in the company's net worth during a reporting period.